METHOD OF PREDICTING COURSE OF MYOCARDIAL INFARCTION BASING ON ASSESSMENT OF MITOCHONDRIAL DYSFUNCTION EXPRESSION Russian patent published in 2014 - IPC G01N33/50 A61K31/495 

FIELD: medicine.

SUBSTANCE: claimed invention relates to medicine, in particular to cardiology, and deals with prediction of a course of myocardial infarction. For this purpose, at the background of the standard therapy in a patient with myocardial infarction carried out is measurement of the level of anaerobic cycle enzymes - succinatedehydrogenase, lactic and pyruvic acids and lipid peroxidation - malonic dialdehyde. After that, trimetazidine is introduced to the patient and after 12 hours the level of enzymes is re-measured. Reduction of their level to normal values testifies to the presence of compensatory abilities of the myocardium energy system and makes it possible to make reliable prediction of low risk of death as a result of acute myocardial infarction.

EFFECT: prediction of the course of myocardial infarction.

2 ex